ijms-logo

Journal Browser

Journal Browser

The Role of Oxidative Stress in Neurodegenerative Diseases

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Biochemistry".

Deadline for manuscript submissions: closed (15 February 2024) | Viewed by 757

Special Issue Editor


E-Mail Website
Guest Editor
Laboratory of Inorganic Chemistry, Department of Chemistry, National and Kapodistrian, University of Athens, 15771 Athens, Greece
Interests: singlet oxygen; oxidative stress; Alzheimer's diseases; α-synuclein Parkinson's diseases; proteinaceous diseases

Special Issue Information

Dear Colleagues,

Oxidative stress is known to play an important role in the pathogenesis of many diseases. It occurs from the imbalance between the production of reactive oxygen species (ROS) and their elimination by protective mechanisms. The Neurodegenerative Diseases include diseases such as Alzheimer's disease, Parkinson's disease, Amyotrophic lateral sclerosis, etc.

Singlet oxygen is an excited state of oxygen O2 which readily oxidizes cellular components such as lipids, proteins, nucleic acids and others. The energy needed for the excitation of oxygen from the ground to the first excited state 1Δg, indicating singlet oxygen, is equal to 92 kJ mol−1. For proteinaceous diseases, the calculated ΔG≠ values vary between 92.8 and 127 kJ mol−1 at 310 K. For reactions in general, a value of 10–30 kJ mol−1 is the requisite activation energy for the diffusion of reactants depending on the reaction and the medium. The similarity of the ΔG≠ values is an indication that a common mechanism may be taking place in the above disorders. We may attribute this common mechanism to the (same) role of the oxidative stress and specifically to that of singlet oxygen (1ΔG).

This Special Issue aims to present the latest research regarding the role of oxidative stress in neurodegenerative diseases. Both original research articles and reviews are welcome.

Dr. Athinoula Petrou
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • singlet oxygen
  • oxidative stress
  • first excited state of oxygen
  • neurodegenerative diseases
  • β-amyloid protein Alzheimer's diseases
  • tau protein Alzheimer's diseases
  • Pick's diseases
  • α-synuclein Parkinson's diseases

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

23 pages, 1494 KiB  
Review
Targeting Mitochondrial Dysfunction and Reactive Oxygen Species for Neurodegenerative Disease Treatment
by Eui-Hwan Choi, Mi-Hye Kim and Sun-Ji Park
Int. J. Mol. Sci. 2024, 25(14), 7952; https://doi.org/10.3390/ijms25147952 (registering DOI) - 21 Jul 2024
Viewed by 459
Abstract
Alzheimer’s disease (AD) and Parkinson’s disease (PD) are the most common neurodegenerative diseases, and they affect millions of people worldwide, particularly older individuals. Therefore, there is a clear need to develop novel drug targets for the treatment of age-related neurodegenerative diseases. Emerging evidence [...] Read more.
Alzheimer’s disease (AD) and Parkinson’s disease (PD) are the most common neurodegenerative diseases, and they affect millions of people worldwide, particularly older individuals. Therefore, there is a clear need to develop novel drug targets for the treatment of age-related neurodegenerative diseases. Emerging evidence suggests that mitochondrial dysfunction and reactive oxygen species (ROS) generation play central roles in the onset and progression of neurodegenerative diseases. Mitochondria are key regulators of respiratory function, cellular energy adenosine triphosphate production, and the maintenance of cellular redox homeostasis, which are essential for cell survival. Mitochondrial morphology and function are tightly regulated by maintaining a balance among mitochondrial fission, fusion, biogenesis, and mitophagy. In this review, we provide an overview of the main functions of mitochondria, with a focus on recent progress highlighting the critical role of ROS−induced oxidative stress, dysregulated mitochondrial dynamics, mitochondrial apoptosis, mitochondria-associated inflammation, and impaired mitochondrial function in the pathogenesis of age-related neurodegenerative diseases, such as AD and PD. We also discuss the potential of mitochondrial fusion and biogenesis enhancers, mitochondrial fission inhibitors, and mitochondria-targeted antioxidants as novel drugs for the treatment of these diseases. Full article
(This article belongs to the Special Issue The Role of Oxidative Stress in Neurodegenerative Diseases)
Show Figures

Figure 1

Back to TopTop